NF-κB signaling and NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome activation are key inflammatory pathways involved in AD, with studies showing that inhibiting these pathways can reduce inflammation and oxidative stress, potentially improving therapeutic outcomes [21] (Figure 1). Here, NFKB1 is linked to Alzheimer disease.